Search Results - "Pirouzfar, Mohammad"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    HLA-A gene knockout using CRISPR/Cas9 system toward overcoming transplantation concerns by Amiri, Farshid, Ranjbar, Maryam, Pirouzfar, Mohammad, Nourigorji, Marjan, Dianatpour, Mehdi

    Published in Egyptian Journal of Medical Human Genetics (05-05-2021)
    “…Background The treatment of many cancers and genetic diseases relies on novel engraftment approaches such as cell therapy and hematopoietic stem cell…”
    Get full text
    Journal Article
  2. 2

    The Effect of Bacterial Peptide p28 on Viability and Apoptosis Status of P53-null HeLa Cells by Abuei, Haniyeh, Behzad-Behbaham, Abbas, Faghihi, Fatemeh, Farhadi, Ali, Dehbidi, Gholam Reza Rafiei, Pirouzfar, Mohammad, Zare, Farahnaz

    Published in Advanced pharmaceutical bulletin (01-10-2019)
    “…Currently, there are several cell lines available with various p53 status including wild-type, mutated, or null cancer cell models each of which are suitable…”
    Get full text
    Journal Article
  3. 3

    Maximizing the recovery of the native p28 bacterial peptide with improved activity and maintained solubility and stability in Escherichia coli BL21 (DE3) by Abuei, Haniyeh, Pirouzfar, Mohammad, Mojiri, Anahita, Behzad-Behbahani, Abbas, Kalantari, Tahereh, Bemani, Peyman, Farhadi, Ali

    Published in Journal of microbiological methods (01-09-2022)
    “…p28 is a natural bacterial product, which recently has attracted much attention as an efficient cell penetrating peptide (CPP) and a promising anticancer…”
    Get full text
    Journal Article
  4. 4

    Development of an optimized RT-LAMP test for the detection of SARS-CoV-2 by Momenifar, Navid, Pirouzfar, Mohammad, Hashemian, Zohreh, Daneshvar Amoli, Abdolreza

    Published in Biologicals (01-11-2023)
    “…SARS-COV-2 is the causative agent of an acute respiratory syndrome called Coronavirus disease 2019 (COVID-19) with a varying mortality rate from 2019 to 2022…”
    Get full text
    Journal Article
  5. 5

    CRISPR/Cas9-mediated knockout of MLL5 enhances apoptotic effect of cisplatin in HeLa cells in vitro by Pirouzfar, Mohammad, Amiri, Farshid, Dianatpour, Mehdi, Takhshid, Mohammad Ali

    Published in EXCLI journal (01-01-2020)
    “…Mixed lineage leukemia 5 (MLL5) transactivates the expression of E6 and E7 oncogenes in cervical cancer cells. In this study, we utilized CRISPR/Cas9 system…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The Effect of Bacterial Peptide p28 on Viability and Apoptosis Statusof P53-null HeLa Cells by Abuei, Haniyeh, Behzad-Behbahani, Abbas, Faghihi, Fatemeh, Farhadi, Ali, Rafiei Dehbidi, Gholam Reza, Pirouzfar, Mohammad, Zare, Farahnaz

    Published in Advanced pharmaceutical bulletin (24-10-2019)
    “…Purpose: Despite all the efforts for discovery of efficient anti-cancer therapeutics, cancer is stilla major health concern worldwide. p28 is a bacterial small…”
    Get full text
    Journal Article